Corporate giving to invest in programs that improve services for communities heavily affected by disease.Advocacy for public health initiatives and policies that maximize patient reach and prevent new infections.We also work with in-country distributors that help register product and forecast drug demand. Partnerships with governments and non-governmental organizations to amplify our impact. The Gilead Advancing Access ® program can provide information for you and your healthcare provider to help you better understand your insurance coverage options for your Gilead medication.If you have insurance: 1- The Gilead Co-pay Coupon Card may be able to help you save on your. The Gilead Advancing Accessco-pay coupon card helps eligible patients who need financial assistance with their co-pays. Talk to your healthcare provider too about ways to afford PrEP. DESCOVY for PrEP could cost as little as 0. No tome Truvada PrEP para reducir su riesgo de infección por VIH si usted es VIH positivo, ha estado expuesto al virus del VIH durante el último mes, o si ha tenido cualquier síntoma (como fiebre, dolor de garganta, sudores nocturnos, glándulas hinchadas, diarrea, dolores en el cuerpo). We are here to help support your ability to afford your Gilead medication. If eligible, Advancing Access may be able to help you lower your co-pay to as little as 0.

Collaborative research with international and local research leaders to target innovative therapies, inform drug delivery and help countries map their disease burdens. The Gilead Advancing Access program is committed to helping you afford your Gilead medicine.

Health systems strengthening to overcome access barriers by bolstering diagnostic, treatment and surveillance capacity.

Responsible generic licensing of our products to enable high-quality, low-cost versions of our HIV and viral hepatitis medicines for individuals in low- and middle-income countries.

Tiered pricing with discounts on medicines based on disease burden and national per-capita income.

To increase education and disease awareness, engage partners strategically and deliver medicines efficiently, we offer: That’s why we work with public health officials, community advocates, researchers, doctors, and patients to understand barriers and opportunities, with a focus on communities impacted by HIV, viral hepatitis and visceral leishmaniasis. Do not take DESCOVY for PrEP unless you are confirmed to be HIV-1 negative. DESCOVY by itself is not a complete treatment for HIV-1. Since that time, we have learned that there is no one-size-fits-all solution to treatment access challenges. Symptoms of new HIV-1 infection include tiredness, fever, joint or muscle aches, headache, sore throat, vomiting, diarrhea, rash, night sweats, and/or enlarged lymph nodes in the neck or groin. Accessed May 9, 2019.ĭisclosures: Hardy reports receiving clinical research funding to his institution from Amgen, Gilead Sciences, Janssen, Merck and ViiV/GlaxoSmithKline, and serving as an advisor or on an advisory board for Gilead, Merck, ViiV/GlaxoSmithKline, CSL Behring (Calimmune) and Enochian.In 2003, Gilead launched pioneering programs to provide access to our medicines in low- and middle-income countries. Official statement responding to Gilead Sciences’ announcement that it will allow Teva to manufacture a generic version of Truvada. The Trump administration has made increasing the use of PrEP a focal point of its 10-year plan to end the HIV epidemic in the U.S. “More immediate actions also are needed to significantly reduce the price and associated medical costs of PrEP, in addition to investments in provider education and capacity building in medically underserved urban and rural areas - particularly in the southern region of the country,” Hardy said.

The card can be used for up to 12 co-pays within 12 months. David Hardy, MD, chair of the HIV Medicine Association, told Infectious Disease News. Sign up and activate the Gilead Co-Pay Coupon Card to save on your monthly prescription of Truvada. “The news that a generic version of Truvada - the only medication currently approved for PrEP - will be available in 2020 rather than 2021 is welcome, but we are unlikely to see a dramatic drop in the price until there is meaningful competition and options for PrEP since one generic manufacturer will have exclusive rights for a period of time,” W. If eligible, Gilead will provide instant approval and the Co-pay Coupon Card can be. A Teva spokesperson did not immediately respond to a question asking how much it would charge. Truvada is manufactured by Gilead Science, Inc. According to the PrEP4All Collaboration, a group of activists seeking wider access to the HIV prevention medication, Gilead charges between $1,600 and $2,000 for a 1-month supply of FTC/TDF. To help us verify your membership and locate your card, please fill out your information below.

Gilead coupon truvada